Sam is Chief Business Officer at Vianautis Bio having joined in 2021 as Vice President of Business Development. Prior to this he served as Director of Business Development at Midatech Pharma, now Biodexa Pharmaceuticals, where he secured and oversaw alliances with pharmaceutical partners. As part of the leadership team at Vianautis, Sam is responsible for partnering and licensing activities and has particular expertise in developing and commercialising innovative platform technologies.

Sam began his career in the biotech industry at Phoremost ltd as a scientist developing target discovery screening platforms before transitioning to alliance management and later business development. He is a molecular biologist by training and completed his PhD in Biological Sciences at the University of Exeter in collaboration with the Drug Discovery Unit in Dundee and DSTL Porton Down.